This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Gastroparesis
and you are
between 18 and 60
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to provide oral domperidone to patients with gastroparesis, between the ages of 18 and 60 years of age, who have failed standard treatment. Standard therapy at the University of Iowa is eating blended foods, liquid diet, Eryped syrup (125 mg TID) 30 minutes before meals, or reglan (20 mg BID).

Provided treatments

  • Drug: Domperidone
Tris trial is registered with FDA with number: NCT02757534. The sponsor of the trial is Yehudith Assouline-Dayan and it is looking for 50 volunteers for the current phase.
Official trial title:
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis